Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Slides:

Advertisements

Similar presentations

Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?

Advertisements

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.

Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

The MASS-DAC Study.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Figure 1 The flowchart depicts the total number of procedures in the Western Denmark Heart Registry (WDHR) and the exclusion of patients; NPR, National.

Successful CTO PCI Associated with Lower Mortality Risk

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Volume 81, Issue 5, Pages (March 2012)

Table 1 Recipient’s characteristics.

Glenn N. Levine et al. JACC 2016;68:

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Annals of Thoracic Surgery

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study Flythe et al. Am J Nephrol 2017;45:

% Heparin + GPI IIb/IIIa Bivalirudin +

The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: A matched propensity score analysis Sean Gallagher,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States Sudhir K. Unni, PhD, MBA, Ruben G.W.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:

Husain N. Alshaikh, MD, Nevin M

Risk Stratification and Interventional Cardiology: Robert L

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Acute Kidney Injury After On-Pump or Off-Pump Coronary Artery Bypass Grafting in Elderly Patients Wilko Reents, MD, Michael Hilker, MD, PhD, Jochen Börgermann,

National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Langsford et al. Am J Nephrol 2017;45: (DOI: / )

Minimally Invasive Direct Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Stenosis:

Coronary Artery Bypass Grafting After Percutaneous Intervention Has Higher Early Mortality: A Meta-Analysis Salah E. Altarabsheh, MD, Salil V. Deo, MS,

P. Michael Grossman et al. JCIN 2009;2:

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

Volume 81, Issue 5, Pages (March 2012)

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

To bypass or stent? The changing rules of an advancing game

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

(A) Multivariable Cox regressions showing the association of higher CHA2DS2-Vasc scores (≥6) and (B) R2CHA2DS2-Vasc scores (≥7) with 1-year mortality (CABG,

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Glenn N. Levine et al. JACC 2011;58:e44-e122

CLINICAL OUTCOMES OF TREATMENT BY PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.

Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.

Leslee J. Shaw et al. JIMG 2010;3:

Baseline characteristics of study population

Davide Capodanno et al. JCIN 2009;2:

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Result of coronary angiogram among patients with and without diabetes admitted with first-time acute coronary syndrome (a significant stenosis was defined.

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Propensity score-matching

Gary L Grunkemeier, PhD, Ruyun Jin, MD The Annals of Thoracic Surgery

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Presentation transcript:

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Fig. 1. Cohort assembly of patients undergoing multi-vessel CABG or PCI between 2004 and 2012 in NIS.

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Table 1. Baseline clinical characteristics of patients undergoing multi-vessel CABG or PCI before and after propensity matching

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Table 2. The incidence of AKI in CABG versus PCI after propensity score matching

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Fig. 2. Comparison of AKI incidences between patients undergoing CABG and PCI stratified with CKD stages.

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Table 3. The in-hospital mortality after CABG versus PCI

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et al. Am J Nephrol 2017;45:217-225 (DOI:10.1159/000455906) Table 4. The length of stay and total charges in CABG and PCI with or without AKI after propensity matching